Greater dyspnea is associated with lower health-related quality of life among European patients with COPD

References

• JoshiMJoshiABartterTSymptom burden in chronic obstructive pulmonary disease and cancerCurr Opin Pulm Med20121829710322262138
   PubMed Web of Science ®Google Scholar
• FerrerMAlonsoJMoreraJChronic obstructive pulmonary disease stage and health-related quality of lifeAnn Intern Med199712712107210799412309
   PubMed Web of Science ®Google Scholar
• StåhlELindbergAJanssonS-AHealth-related quality of life is related to COPD disease severityHealth Qual Life Outcomes200535616153294
   PubMedGoogle Scholar
• StahlEWadboMBengtssonTStromKLofdahlC-GHealth-related quality of life, symptoms, exercise capacity and lung function during treatment for moderate to severe COPDJ DRUG Assess2002518194
   Google Scholar
• MiravitllesMAlvarez-SalaJLLamarcaRIMPAC Study GroupTreatment and quality of life in patients with chronic obstructive pulmonary diseaseQual Life Res200211432933812086118
   PubMed Web of Science ®Google Scholar
• JonesPWActivity limitation and quality of life in COPDCOPD20074327327817729072
   PubMedGoogle Scholar
• FaulknerMAHillemanDEThe economic impact of chronic obstructive pulmonary diseaseExpert Opin Pharmacother20023321922811866672
   PubMedGoogle Scholar
• DarkowTKadlubekPJShahHPhillipsALMartonJPA retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary diseaseJ Occup Environ Med2007491223017215710
   PubMed Web of Science ®Google Scholar
• SinDDStafinskiTNgYCBellNRJacobsPThe impact of chronic obstructive pulmonary disease on work loss in the United StatesAm J Respir Crit Care Med2002165570470711874818
   PubMed Web of Science ®Google Scholar
• JonesPWBoshTKQuality of life changes in COPD patients treated with salmeterolAm J Respir Crit Care Med19971554128312899105068
   PubMed Web of Science ®Google Scholar
• TonnelAPerezTGrosboisJEffect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPDInt J Chron Obstruct Pulmon Dis20083230131018686739
   PubMedGoogle Scholar
• BrusascoVHodderRMiravitllesMKorduckiLTowseLKestenSHealth outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax2006585399404
   Google Scholar
• ToyELBeaulieuNUMchaleJMTreatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costsRespir Med2011105343544120880687
   PubMed Web of Science ®Google Scholar
• MahlerDAKerwinEAyersTFLIGHT1 and FLIGHT2: efficacy and safety of QVA149 (indacaterol/glycopyrrolate) versus its mono-components and placebo in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201519291068107926177074
   PubMed Web of Science ®Google Scholar
• KornmannODahlRCentanniSLIGHT-2 (Indacaterol Efficacy Evaluation Using 150-µg Doses with COPD Patients) study investigatorsOnce-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparisonEur Respir J201137227327920693243
   PubMed Web of Science ®Google Scholar
• KerwinEHebertJGallagherNEfficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 studyEur Respir J20124051106111423060624
   PubMed Web of Science ®Google Scholar
• DonohueJFFogartyCLotvallJINHANCE Study InvestigatorsOnce-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropiumAm J Respir Crit Care Med2010182215516220463178
   PubMed Web of Science ®Google Scholar
• PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990425210450
   PubMed Web of Science ®Google Scholar
• DransfieldMTBaileyWCraterGEmmettAO’DellDMYawnBDisease severity and symptoms among patients receiving monotherapy for COPDPrim Care Respir J2011201465320886200
   PubMedGoogle Scholar
• Ehteshami-AfsharSFitzGeraldJMDoyle-WatersMMSadatsafaviMThe global economic burden of asthma and chronic obstructive pulmonary diseaseInt J Tuberc Lung Dis2016201112326688525
   PubMed Web of Science ®Google Scholar
• BurneyPGJPatelJNewsonRMinelliCNaghaviMGlobal and regional trends in COPD mortality, 1990–2010Eur Respir J20154551239124725837037
   PubMed Web of Science ®Google Scholar
• European Respiratory SocietyThe European Lung White BookSheffield, UKEuropean Respiratory Society Publications Office2013
   Google Scholar
• ParshallMBSchwartzsteinRMAdamsLAn official American thoracic society statement: update on the mechanisms, assessment, and management of dyspneaAm J Respir Crit Care Med2012185443545222336677
   PubMed Web of Science ®Google Scholar
• RocheNChavannesNHMiravitllesMCOPD symptoms in the morning: impact, evaluation and managementRespir Res20131411224143997
   PubMed Web of Science ®Google Scholar
• DemirGAkkocaODoganRSaryalSKarabiyikogluGThe evaluation of dyspnea and quality of life in COPDTuberk Toraks2003514365372 Indonesian15143383
   PubMedGoogle Scholar
• Elias HernandezMTOrtega RuizFSanchez RieraHPapel de la disnea en la calidad de vida del paciente con enfermedad pulmonar obstructiva crónica [Role of dyspnea in quality of life of the patient with chronic obstructive pulmonary disease]Arch Bronconeumol1999356261266 Spanish10410205
   PubMedGoogle Scholar
• RiesALImpact of chronic obstructive pulmonary disease on quality of life: the role of dyspneaAm J Med200611910 Suppl 1122016996895
   PubMed Web of Science ®Google Scholar
• JonesPWHardingGBerryPWiklundIChenW-HKline LeidyNDevelopment and first validation of the COPD assessment testEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• BrooksSMSurveillance for respiratory hazardsATS News198281216
   Google Scholar
• BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
   PubMed Web of Science ®Google Scholar
• JonesPWCOPD assessment test – rationale, development, validation and performanceCOPD201310226927123547637
   PubMedGoogle Scholar
• CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
   PubMedGoogle Scholar
• MaruishMENEW SF36v2 User Guide3rd EdLincoln, RIQuality Metric2011
   Google Scholar
• BrazierJERobertsJThe estimation of a preference-based measure of health from the SF-12Med Care200442985185915319610
   PubMed Web of Science ®Google Scholar
• ReillyMCZbrozekASDukesEMThe validity and reproducibility of a work productivity and activity impairment instrumentPharmacoeconomics19934535336510146874
   PubMed Web of Science ®Google Scholar
• LandisSHMuellerovaHManninoDMContinuing to confront COPD international patient survey: methods, COPD prevalence, and disease burden in 2012–2013Int J COPD20149597607
   Google Scholar
• JustineMTahirahFMohanVHealth-related quality of life, lung function and dyspnea rating in COPD patientsMonaldi Arch Chest Dis2013793–411612024761529
   PubMedGoogle Scholar
• TsiligianniIKocksJTzanakisNSiafakasNvan der MolenTFactors that influence disease-specific quality of life or health status in patients with COPD: a systematic review and meta-analysis of Pearson correlationsPrim Care Respir J201120325726821472192
   PubMedGoogle Scholar
• MahlerDATomlinsonDOlmsteadEMTostesonANO’ConnorGTChanges in dyspnea, health status, and lung function in chronic airway diseaseAm J Respir Crit Care Med1995151161657812573
   PubMed Web of Science ®Google Scholar
• JonesPWAdamekLNadeauGBanikNComparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classificationEur Respir J201342364765423258783
   PubMed Web of Science ®Google Scholar
• LinF-JPickardASKrishnanJAMeasuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short formBMC Med Res Methodol2014147824934150
   PubMed Web of Science ®Google Scholar
• AkinciACPinarRDemirTThe relation of the subjective dyspnoea perception with objective dyspnoea indicators, quality of life and functional capacity in patients with COPDJ Clin Nurs2013227–896997622765349
   PubMed Web of Science ®Google Scholar